XHS Quote, Financials, Valuation and Earnings

Global X Genomics & Biotechnology ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Global X Genomics & Biotechnology ETF.

SPDR S&P Health Care Services ETF has a beta of 1.046, which suggesting that the stock is 4.633% more volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.784%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 0.33%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco Biotechnology & Genome ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Invesco Biotechnology & Genome ETF.

SPDR S&P Health Care Services ETF has a beta of 1.046, which suggesting that the stock is 4.633% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.840, suggesting its less volatile than the S&P 500 by 15.98%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 0.33%. Invesco Biotechnology & Genome ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.

SPDR S&P Health Care Equipment ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than SPDR S&P Health Care Equipment ETF.

SPDR S&P Health Care Services ETF has a beta of 1.046, which suggesting that the stock is 4.633% more volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.069, suggesting its more volatile than the S&P 500 by 6.861%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.04 per share corresponding to a yield of 0.33%. SPDR S&P Health Care Equipment ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.